Water-soluble acetaminophen analogs
US-2020002364-A1 · Jan 2, 2020 · US
Carbonate prodrugs and methods of using the same
US11136342B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-11136342-B2 |
| Application number | US-201916459430-A |
| Country | US |
| Kind code | B2 |
| Filing date | Jul 1, 2019 |
| Priority date | May 20, 2008 |
| Publication date | Oct 5, 2021 |
| Grant date | Oct 5, 2021 |
How to read this patent
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
- Title
What the patent document calls the invention.
- Abstract
A short plain-language summary of the technical disclosure.
- Assignees and inventors
Who owns or filed the patent and who is credited as inventor.
- Key dates
Filing, priority, publication, and grant dates set the timeline.
- First independent claim
The legal scope of protection — read this for what is actually claimed.
- CPC / IPC classifications
Technology tags used to group this patent with similar filings.
- Citations and related patents
Prior art links and similar publications in this corpus.
Abstract
Official abstract text for this publication.
The present invention provides carbonate prodrugs which comprise a carbonic phosphoric anhydride prodrug moiety attached to the hydroxyl or carboxyl group of a parent drug moiety. The prodrugs may provide improved physicochemical properties over the parent drug. Also provided are methods of treating a disease or condition that is responsive to the parent drug using the carbonate prodrugs, as well as kits and unit dosages.
First claim
Opening claim text (preview).
What is claimed is: 1. A formulation comprising: (i) a prodrug comprising: (a) a moiety of parent drug, wherein the parent drug comprises a hydroxyl group or a carboxyl group; and (b) a prodrug moiety of the formula: wherein the prodrug moiety is bound to the moiety of the parent drug at the hydroxyl or carboxyl group providing a carbonate moiety; or a pharm…
Assignees
Inventors
Classifications
Patent family
Related publications grouped by family.
External sources
Next steps
Free tools are coming soon. Tell us what you want to track and we'll notify you.
Frequently asked questions
Answers are generated from the same data shown on this page.
- What does patent US11136342B2 cover?
- The present invention provides carbonate prodrugs which comprise a carbonic phosphoric anhydride prodrug moiety attached to the hydroxyl or carboxyl group of a parent drug moiety. The prodrugs may provide improved physicochemical properties over the parent drug. Also provided are methods of treating a disease or condition that is responsive to the parent drug using the carbonate prodrugs, as we…
- Who is the assignee on this patent?
- Acorda Therapeutics Inc
- What technology area does this patent fall under?
- Primary CPC classification C07F9/096. Mapped technology areas include Chemistry & Metallurgy.
- When was this patent published?
- Publication date Tue Oct 05 2021 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
- What related patents are in patentsdb?
- We list 9 related publications on this page (citations in our corpus or others sharing the same primary CPC).